MLYS Mineralys Therapeutics, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:05
Aug 17
Aug 17
Shares options positioning net conviction data.
Shares options positioning data showing net conviction based on fund holdings, no directional view.
MED
13:00
Aug 17
Aug 17
Highlights largest single-fund new positions.
Highlights largest single-fund new positions for Q2 2026, no directional view.
MED
12:53
Aug 17
Aug 17
Reports widest ownership across specialist funds
"Reports widest Q2 2026 ownership across 95 specialist funds based on 13F filings, no directional view."
MED
12:49
Aug 17
Aug 17
Reports most added positions across funds
"Reports most added positions across specialist funds from Q1 to Q2 2026, no directional view."
MED
12:01
Aug 17
Aug 17
Reports Q2 net conviction from specialist funds
Reports Q2 net conviction chart based on 13F filings from specialist funds.
MED
11:58
Aug 17
Aug 17
Reports widest Q2 ownership among specialist funds
Reports the widest Q2 2026 ownership across 93 specialist funds based on 13F filings.
MED
11:50
Aug 17
Aug 17
Reports most added positions by specialist funds
Reports the most added positions by specialist funds from Q1 to Q2 2026.
MED
About MLYS Analyst Coverage
Buzzberg tracks MLYS (Mineralys Therapeutics, Inc.) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 7 total trade ideas tracked. Latest voices: seedy19tron.